Tff Pharmaceuticals Inc Asset Turnover Ratio (TFFP), as of third quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Tff Pharmaceuticals Inc  (NASDAQ: TFFP)
 

Tff Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Tff Pharmaceuticals Inc's asset turnover ratio has remained unchanged compare to previous quarter at 0.07 in the third quarter (Sep 30 2024)

Within sector 174 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2024 compared to the preceding quarter from 3096 to 3376.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TFFP Asset Turnover Ratio (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Asset Change -40.51 % -16.93 % -49.56 % 28.4 % -26.41 %
Y / Y Revenue Change -17.62 % 95.06 % 295.25 % -63.46 % 167.99 %
Asset Turnover Ratio (TTM) 0.07 0.07 0.05 0.04 0.05
TFFP's Total Ranking # 3376 # 3096 # 2568 # 3441 #
Seq. Asset Change -21.45 % 22.7 % -74.96 % 146.48 % 9.7 %
Seq. Revenue Change -70.26 % 219.88 % 77.84 % -51.31 % -29.57 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 175
Healthcare Sector # 505
Overall Market # 3376

Asset Turnover Ratio Statistics
High Average Low
0.12 0.04 0
(Sep 30 2024)   (Jun 30 2021)




TFFP Company Profile • Back to TFFP Efficiency Comparisons • Compare TFFP Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Assets at quarter ending Sep 30 2024
Zai Lab Limited  0.36 $ 355.748  Millions$ 999.362  Millions
Outset Medical Inc   0.36 $ 112.490  Millions$ 316.867  Millions
Sutro Biopharma Inc   0.35 $ 160.955  Millions$ 453.753  Millions
Biogen Inc   0.35 $ 9,607.500  Millions$ 27,132.425  Millions
Bausch Health Companies Inc   0.35 $ 9,474.000  Millions$ 26,824.500  Millions
Zimmer Biomet Holdings Inc   0.35 $ 7,595.400  Millions$ 21,547.400  Millions
Amarin Corp Plcuk  0.35 $ 279.069  Millions$ 793.042  Millions
Invo Fertility Inc   0.35 $ 6.228  Millions$ 17.724  Millions
Ultragenyx Pharmaceutical Inc   0.35 $ 522.745  Millions$ 1,488.723  Millions
Bausch and Lomb Corp  0.35 $ 4,684.000  Millions$ 13,375.000  Millions
Amgen Inc   0.35 $ 32,534.000  Millions$ 92,981.000  Millions
Celularity Inc   0.35 $ 48.200  Millions$ 138.010  Millions
Ss Innovations International Inc  0.35 $ 11.638  Millions$ 33.473  Millions
Opko Health Inc   0.35 $ 711.409  Millions$ 2,055.422  Millions
Jazz Pharmaceuticals Plc  0.34 $ 3,992.712  Millions$ 11,584.505  Millions
Lipocine Inc   0.34 $ 7.935  Millions$ 23.045  Millions
Enzo Biochem Inc  0.34 $ 30.314  Millions$ 88.400  Millions
Universe Pharmaceuticals Inc  0.34 $ 23,024.458  Millions$ 67,953.393  Millions
Veracyte Inc   0.34 $ 407.966  Millions$ 1,206.082  Millions
Rhythm Pharmaceuticals Inc   0.34 $ 112.530  Millions$ 334.203  Millions
Prestige Consumer Healthcare Inc   0.33 $ 1,110.159  Millions$ 3,324.137  Millions
Scpharmaceuticals Inc   0.33 $ 30.278  Millions$ 90.865  Millions
Petvivo Holdings Inc   0.33 $ 0.969  Millions$ 2.907  Millions
Innoviva Inc   0.33 $ 413.572  Millions$ 1,241.912  Millions
Acutus Medical Inc   0.33 $ 13.347  Millions$ 40.817  Millions
Utah Medical Products Inc  0.33 $ 43.301  Millions$ 132.656  Millions
Arcutis Biotherapeutics Inc   0.33 $ 138.708  Millions$ 425.505  Millions
Viatris Inc   0.33 $ 15,048.500  Millions$ 46,278.325  Millions
Travere Therapeutics Inc   0.32 $ 203.447  Millions$ 626.998  Millions
The Cooper Companies Inc   0.32 $ 3,896.300  Millions$ 12,032.375  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.